Protective effect of porphyran (cas 11016-36-7) isolated from discolored nori (Porphyra yezoensis) on lipopolysaccharide-induced endotoxin shock in mice
-
Add time:08/19/2019 Source:sciencedirect.com
porphyran (cas 11016-36-7), a sulfated polysaccharide, isolated from discolored nori (Porphyra yezoensis) (dc-porphyran) and one fraction (F1) purified from dc-porphyran by DEAE-chromatography showed the protective effects on LPS-induced endotoxin shock in mice. Intraperitoneal (i.p.) treatment with dc-porphyran or F1 (100 mg/kg) 60 min prior to i.p. injection of LPS (30 mg/kg) completely protected mice from LPS lethality. At 10 mg/kg concentration, F1 demonstrated more protection than dc-porphyran. Intravenous (i.v.) challenge of LPS, even at 20 mg/kg, was more lethal than i.p. administration; i.v. injection of F1 (100 mg/kg) with LPS significantly improved the survival rate. However, i.v. dc-porphyran (100 mg/kg) produced an even lower survival rate than that of LPS alone. We examined pro-inflammatory mediators such as NO and TNF-α in serum. F1 significantly reduced the levels of these markers. Additionally, F1 significantly decreased the malondialdehyde level in the liver, a marker of oxidative stress, while dc-porphyran had almost no effect. Furthermore, F1 significantly decreased the production of TNF-α and NO in peritoneal exudate cells harvested from LPS-challenged mice, while dc-porphyran treatment showed a lesser decrease. Our results suggest that porphyran isolated from discolored nori, especially F1, is capable of suppressing LPS-induced endotoxin shock in vivo.
We also recommend Trading Suppliers and Manufacturers of porphyran (cas 11016-36-7). Pls Click Website Link as below: cas 11016-36-7 suppliers
Prev:In vivo antihyperlipidemic and antioxidant activity of porphyran (cas 11016-36-7) in hyperlipidemic mice
Next:Antioxidant and anti-inflammatory activities of porphyran (cas 11016-36-7) isolated from discolored nori (Porphyra yezoensis)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and drug release in vitro of porphyran (cas 11016-36-7) carrying 5-Fluorouracil08/25/2019
- Investigation of the factors influencing the molecular weight of porphyran (cas 11016-36-7) and its associated antifungal activity08/24/2019
- Immuno-modulation effect of sulphated polysaccharide (porphyran (cas 11016-36-7)) from Porphyra vietnamensis08/23/2019
- In vitro antioxidant activities of acetylated, phosphorylated and benzoylated derivatives of porphyran (cas 11016-36-7) extracted from Porphyra haitanensis08/22/2019
- Regioselective syntheses of sulfated porphyran (cas 11016-36-7)s from Porphyra haitanensis and their antioxidant and anticoagulant activities in vitro08/21/2019
- Antioxidant and anti-inflammatory activities of porphyran (cas 11016-36-7) isolated from discolored nori (Porphyra yezoensis)08/20/2019
- In vivo antihyperlipidemic and antioxidant activity of porphyran (cas 11016-36-7) in hyperlipidemic mice08/18/2019
- Increase in anti-inflammatory activities of radical-degraded porphyran (cas 11016-36-7)s isolated from discolored nori (Pyropia yezoensis)08/17/2019
- Comparative analysis of prebiotic effects of seaweed polysaccharides laminaran, porphyran (cas 11016-36-7), and ulvan using in vitro human fecal fermentation08/16/2019